Skip to main content

Lilly Endowment Inc's Form 4 filing

Eli Lilly & Co (LLY) · filed Nov 13, 2025

Accession no.
0000316011-25-000069
Filed
Nov 13, 2025
Trade date
Nov 12, 2025
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 20 non-derivative transactions. Open-market sales total $308.4M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lilly Endowment IncCIK 000031601110% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 12, 2025Common StockSSaleDisposed−828$1,001.93F1−$829,598.0493,411,150Direct
Nov 12, 2025Common StockSSaleDisposed−7,585$1,003.12F2−$7,608,665.293,403,565Direct
Nov 12, 2025Common StockSSaleDisposed−22,131$1,004.10F3−$22,221,737.193,381,434Direct
Nov 12, 2025Common StockSSaleDisposed−23,568$1,004.97F4−$23,685,132.9693,357,866Direct
Nov 12, 2025Common StockSSaleDisposed−23,863$1,006.02F5−$24,006,655.2693,334,003Direct
Nov 12, 2025Common StockSSaleDisposed−16,383$1,007.10F6−$16,499,319.393,317,620Direct
Nov 12, 2025Common StockSSaleDisposed−8,913$1,007.97F7−$8,984,036.6193,308,707Direct
Nov 12, 2025Common StockSSaleDisposed−17,985$1,009.00F8−$18,146,86593,290,722Direct
Nov 12, 2025Common StockSSaleDisposed−20,000$1,009.99F9−$20,199,80093,270,722Direct
Nov 12, 2025Common StockSSaleDisposed−19,892$1,011.18F10−$20,114,392.5693,250,830Direct
Nov 12, 2025Common StockSSaleDisposed−21,559$1,011.96F11−$21,816,845.6493,229,271Direct
Nov 12, 2025Common StockSSaleDisposed−16,749$1,012.94F12−$16,965,732.0693,212,522Direct
Nov 12, 2025Common StockSSaleDisposed−11,638$1,014.17F13−$11,802,910.4693,200,884Direct
Nov 12, 2025Common StockSSaleDisposed−16,274$1,015.16F14−$16,520,713.8493,184,610Direct
Nov 12, 2025Common StockSSaleDisposed−13,415$1,016.01F15−$13,629,774.1593,171,195Direct
Nov 12, 2025Common StockSSaleDisposed−7,188$1,017.16F16−$7,311,346.0893,164,007Direct
Nov 12, 2025Common StockSSaleDisposed−47,073$1,018.02F17−$47,921,255.4693,116,934Direct
Nov 12, 2025Common StockSSaleDisposed−7,833$1,018.83F18−$7,980,495.3993,109,101Direct
Nov 12, 2025Common StockSSaleDisposed−1,281$1,019.92F19−$1,306,517.5293,107,820Direct
Nov 12, 2025Common StockSSaleDisposed−842$1,021.07F20−$859,740.9493,106,978Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,001.213 to $1,002.20, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18), (19), and (20) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,002.52 to $1,003.51, inclusive.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,003.52 to $1,004.515, inclusive.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,004.53 to $1,005.527, inclusive.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,005.535 to $1,006.53, inclusive.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,006.54 to $1,007.53, inclusive.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,007.54 to $1,008.52, inclusive.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,008.54 to $1,009.535, inclusive.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,009.54 to $1,010.53, inclusive.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,010.54 to $1,011.53, inclusive.

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,011.55 to $1,012.545, inclusive.

Referenced by the price of 1 transaction in Table I.

F12

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,012.55 to $1,013.532, inclusive.

Referenced by the price of 1 transaction in Table I.

F13

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,013.59 to $1,014.56, inclusive.

Referenced by the price of 1 transaction in Table I.

F14

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,014.59 to $1,015.58, inclusive.

Referenced by the price of 1 transaction in Table I.

F15

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,015.59 to $1,016.439, inclusive.

Referenced by the price of 1 transaction in Table I.

F16

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,016.60 to $1,017.54, inclusive.

Referenced by the price of 1 transaction in Table I.

F17

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,017.63 to $1,018.62, inclusive.

Referenced by the price of 1 transaction in Table I.

F18

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,018.65 to $1,019.421, inclusive.

Referenced by the price of 1 transaction in Table I.

F19

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,019.651 to $1,020.375 inclusive.

Referenced by the price of 1 transaction in Table I.

F20

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,020.664 to $1,021.661, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)